276 results on '"Filipiak, Krzysztof"'
Search Results
2. Pharmacotherapy of heart failure A.D. 2023. Expert opinion of Working Group on Cardiovascular Pharmacotherapy, Polish Cardiac Society
3. Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society
4. Successful percutaneous transluminal angioplasty to treat superior vena cava syndrome
5. Rules for using reduced doses of non-vitamin K antagonist oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation. The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society
6. The use of GLP-1 analogues in the treatment of diabetes in patients with cardiovascular diseases. The expert opinion of the Working Group of Cardiovascular Pharmacotherapy of the Polish Cardiac Society
7. More for less — long-term survival modeling for surgical aortic valve replacement follow-up: The division between a ministernotomy and a full sternotomy approach
8. HIV-infected patients on combined antiretroviral treatment had a similar level of arterial stiffness to the patients with ST-segment elevation myocardial infarction
9. Protamine sulfate during transcatheter aortic valve implantation (PS TAVI) — a single-center, single-blind, randomized placebo-controlled trial
10. The prevalence and association of major ECG abnormalities with clinical characteristics and the outcomes of real-life heart failure patients — Heart Failure Registries of the Eu ropean Society of Cardiology
11. Expression of versican mRNA transcript to predict cardiac remodelling after myocardial infarction
12. Temporal trends of transcatheter aortic valve implantation in high-volume academic center over 10 years
13. Intraosseous versus intravenous access while wearing personal protective equipment: a meta-analysis in the era of COVID-19
14. D-dimer levels predict COVID-19 severity and mortality
15. Why epinephrine should not always be used in pediatric cardiac arrest?
16. New hope for patients and challenges for the multidisciplinary arrhythmia team: a hybrid convergent approach for atrial fibrillation treatment
17. An optimal chest compression technique using personal protective equipment during resuscitation in the COVID-19 pandemic: a randomized crossover simulation study
18. Effect of amiodarone and lidocaine on shock-refractory cardiac arrest: a systematic review and meta-analysis
19. Who started the history of invasive cardiology in Poland? A commentary to the letter by Prof. Robert Rudowski
20. Management of bleeding in patients hospitalized in the intensive cardiac care unit: expert opinion of the Association of Intensive Cardiac Care and Section of Cardiovascular Pharmacotherapy of the Polish Cardiac Society in cooperation with specialists in other fields of medicine
21. The rationale and design of the LATTEE registry – the first multicenter project on the Scientific Platform of the “Club 30” of the Polish Cardiac Society
22. Non-vitamin K antagonist oral anticoagulants in the treatment of coronary and peripheral atherosclerosis
23. A rare case of mitral stenosis: caseous calcification of the mitral annulus
24. A serial three- and nine-year optical coherence tomography evaluation of neoatherosclerosis progression after sirolimus- and paclitaxel- -eluting stent implantation
25. Dysregulations of miRNAs and galectin-3 may underlie left ventricular dilatation in patients with systolic heart failure
26. miR-1, miR-21, and galectin-3 in hypertensive patients with symptomatic heart failure and left ventricular hypertrophy
27. Giant small-cell neuroendocrine carcinoma infiltrating the heart
28. Risk factors for adverse outcomes of patients with acute coronary syndrome: single-centre experience with long-term follow-up of treated patients
29. Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study
30. EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature
31. Long-term prognosis following acute coronary syndromes: a prospective observational study of an unselected group treated in the 24/7 cardiac catheterisation laboratory at a university hospital
32. Factors influencing high-quality chest compressions during cardiopulmonary resuscitation scenario, according to 2015 American Heart Association Guidelines
33. Utilisation of lipid-lowering therapies in outpatient settings in Poland: epidemiological survey Economedica Dyslipidaemia 2015
34. Epidemiology of dyslipidaemia in professional drivers: results of RACER-ABPM (Risk of Adverse Cardiovascular Events among professional dRivers in Poland — Ambulatory Blood Pressure Monitoring) study
35. Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: a systematic review and meta-analysis
36. Negative predictors of treatment success in outpatient therapy of arterial hypertension in Poland. Results of the CONTROL NT observational registry
37. Thromboelastography for predicting bleeding in patients with aortic stenosis treated with transcatheter aortic valve implantation
38. Odległa obserwacja wyników badania SMILE-4 — nowe dane na temat korzyści z przyjmowania zofenoprilu
39. Wieloośrodkowe badania nad walsartanem — dlaczego kolejne dane o jego wpływie na ciśnienie centralne są potrzebne?
40. Haematological indices as predictors of atrial fibrillation following isolated coronary artery bypass grafting, valvular surgery, or combined procedures: a systematic review with meta-analysis
41. Heart failure patients with a previous coronary revascularization: results from the ESC-HF Registry
42. Peripheral ARtery Atherosclerotic DIsease and SlEep disordered breathing (PARADISE) trial — protocol for an observational cohort study
43. Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy
44. Anti-aggregation therapy in patients with acute coronary syndrome — recommendations for medical emergency teams. Experts’ standpoint
45. Dabigatran — what is new that we have learned from the papers recently published?
46. Tikagrelor — więcej, powszechniej, wcześniej…
47. The effects of CD4 nadirs on vessel stiffness in HIV patients undergoing antiretroviral therapy
48. New Impact Factor
49. Prognostic factors in heart failure — are they all equally important?
50. Polish Forum for Prevention Guidelines on Prophylactic Pharmacotherapy: update 2017
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.